Paper - WANFANG MED ONLINE

You Position: Home > Paper

Advances in understanding of idiopathic pulmonary fibrosis

( views:187, downloads:12 )

Author:: No author available

Journal Title:: CHINESE MEDICAL JOURNAL

Issue:: 7

DOI:: 10.3760/cma.j.issn.0366-6999.2009.07.016

Key Word:: idiopathic pulmonary fibrosis;adrenal cortex hormones;immunosuppressive agents

Abstract： @@ Our understanding of idiopathic pulmonary fibrosis (IPF) has undergone major changes in recent years.

Reference

[1]Antoniou KM,Desai SR,Nicholson AG,etc.Idiopathic pulmonary fibrosis: outcome in relation to smoking status.[J].2008,177(2).
[2]MacNee W,Verschakelen J,Petruzzelli S,etc.High-dose acetylcysteine in idiopathic pulmonary fibrosis.[J].2005,353(21).
[3]Kazerooni EA,Gross BH,Lama V,etc.Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test.[J].2006,174(7).
[4]Collard HR,Walter N,King TE Jr.Current perspectives on the treatment of idiopathic pulmonary fibrosis.[J].2006,3(4).
[5]G, Raghu,W C, Johnson,D, Lockhart,etc.Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study.[J].1999,159.
[6]White ES,Atrasz RG,Martinez FJ,etc.An essential role for fibronectin extra type III domain A in pulmonary fibrosis.[J].2008,177(6).
[7]Gary W, Hunninghake.Antioxidant therapy for idiopathic pulmonary fibrosis.[J].2005,353(21).
[8]Bradford WZ,Noble PW,Raghu G,etc.A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.[J].2004,350(2).
[9]Xu J,Torres Gonzalez E,Brigham K,etc.Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis.[J].2006,35(4).
[10]King-TE Jr,Gotway MB,Freemer MM.Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias.[J].2007,62(6).
[11]Tomfohr J,Brass DM,Schwartz DA,etc.Using mouse genomics to understand idiopathic interstitial fibrosis.[J].2007,4(1).
[12]Olman MA,Brown KK,Lynch DA,etc.Acute exacerbations of idiopathic pulmonary fibrosis.[J].2007,176(7).
[13]Nathan SD,Shlobin OA,Zisman DA,etc.Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis.[J].2008,133(3).
[14]Yamauchi S,Nagai S,Taniyama M,etc.Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis.[J].2002,41(12).
[15]Sestini P,Black CM,Nicholson AG,etc.Interstitial vascularity in fibrosing alveolitis.[J].2003,167(3).
[16]Wells AU.Antioxidant therapy in idiopathic pulmonary fibrosis: hope is kindled. Society for Clinical Respiratory Physiology[J].2006,27(4).
[17]Nathan SD,Noble PW,Tuder RM.Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.[J].2007,175(9).
[18]Nina M, Patel,David J, Lederer,Alain C, Borczuk,etc.Pulmonary hypertension in idiopathic pulmonary fibrosis.[J].2007,132(3).
[19]Olson AL,Brown KK,Swigris JJ,etc.Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.[J].2007,176(3).
[20]Raghu G,Bradford WZ,Weycker D,etc.Incidence and prevalence of idiopathic pulmonary fibrosis.[J].2006,174(7).
[21]Paparountas T,Chatziioannou A,Oikonomou N,etc.Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis.[J].2007,176(11).
[22]Ziesche, Rolf,Hofbauer, Elisabeth,Wittmann, Karin,etc.A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary Fibrosis.[J].1999,341(17).
[23]Chapman HA,Liotta L,Sheppard D,etc.Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group.[J].2002,166(2).
[24]Lederer DJ,Wilt JS,D'Ovidio F,etc.Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis.[J].2006,174(6).
[25]Rocha NS,Malheiros T,Pereira CA,etc.Survival in idiopathic pulmonary fibrosis-cytotoxic agents compared to corticosteroids.[J].2006,100(2).
[26]Bayongan E,Munger JS,Yang Z,etc.Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis.[J].2008,177(1).
[27]Oury TD,Ryynanen MJ,Kliment CR,etc.Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.[J].2008,177(3).
[28]Leconte I,Behr J,King-TE Jr,etc.BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.[J].2008,177(1).
[29]Honore I,Chambellan A,Aubier M,etc.Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis.[J].2003,167(7).
[30]Rubin LJ,Galie N,Simonneau G,etc.Bosentan therapy for pulmonary arterial hypertension.[J].2002,346(12).
[31]Tsuboi E,Nakata K,Ohi M,etc.Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.[J].2005,171(9).
[32]Kevin R. Flaherty.High-Resolution Computed Tomography and the Many Faces of Idiopathic Pulmonary Fibrosis[J].2008,177(4).
[33]Fisher AJ,Anderson RL,Corris PA,etc.Pulmonary fibrosis: rate of disease progression as a trigger for referral for lung transplantation.[J].2007,62(12).
[34]Gauldie J,Ask K,Martin GE,etc.Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls.[J].2006,3(4).
[35]Pardo A,Selman M.Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.[J].2006,3(4).
[36]Hunninghake GW,Schwarz MI.Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.[J].2007,4(5).
[37]Diette GB,Merriman B,Fishman EK,etc.Do high-resolution CT findings of usual interstitial pneumonitis obviate lung biopsy? Views of pulmonologists.[J].2005,72(2).
[38]Fell CD,Martinez FJ.The impact of pulmonary arterial hypertension on idiopathic pulmonary fibrosis.[J].2007,131(3).
[39]David A, Zisman,Arun S, Karlamangla,David J, Ross,etc.High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.[J].2007,132(3).
[40]Raghu G.Idiopathic pulmonary fibrosis: treatment options in pursuit of evidence-based approaches. Society for Clinical Respiratory Physiology[J].2006,28(3).
[41]Boster A,Javed A,Tselis A,etc.Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician.[J].2008,7(2).
[42]Pardo A,Selman M,Lynch JP,etc.Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.[J].2004,64(4).
[43]Tabuena RP,Mishima M,Handa T,etc.Cell profiles of bronchoalveolar lavage fluid as prognosticators of idiopathic pulmonary fibrosis/usual interstitial pneumonia among Japanese Patients.[J].2005,72(5).
[44]Bateman ED,Desai SR,Grutters JC,etc.Interstitial lung disease: effects of thin-section CT on clinical decision making.[J].2006,238(2).
[45]Wilson JW,Williams TJ.Challenges in pulmonary fibrosis: 7--Novel therapies and lung transplantation.[J].2008,63(3).